Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q.
Patients with cholestasis-lymphedema syndrome (CLS) suffer severe neonatal cholestasis that usually lessens during early childhood and becomes episodic; they also develop chronic severe lymphedema. The genetic cause of CLS is unknown. We performed a genome screen, using DNA from eight Norwegian patients with CLS and from seven unaffected relatives, all from an extended pedigree. Regions potentially shared identical by descent in patients were further characterized in a larger set of Norwegian patients. The patients manifest extensive allele and haplotype sharing over the 6.6-cM D15S979-D15S652 region: 30 (83.3%) of 36 chromosomes of affected individuals carry a six-marker haplotype not found on any of the 32 nontransmitted parental chromosomes. All Norwegian patients with CLS are likely homozygous for the same disease mutation, inherited from a shared ancestor.
Bull
L N
LN
Liver Center Laboratory, San Francisco General Hospital, San Francisco, CA 94110, USA. lbull@medsfgh.ucsf.edu
Roche
E
E
Song
E J
EJ
Pedersen
J
J
Knisely
A S
AS
van Der Hagen
C B
CB
Eiklid
K
K
Aagenaes
O
O
Freimer
N B
NB
D000483:Alleles; D002779:Cholestasis / Q000235:genetics*; D002874:Chromosome Mapping; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics*; D003241:Consanguinity; D005260:Female; D005808:Genes, Recessive / Q000235:genetics; D006239:Haplotypes / Q000235:genetics; D006720:Homozygote; D006801:Humans; D008209:Lymphedema / Q000235:genetics*; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D009664:Norway; D010375:Pedigree; D013577:Syndrome